Aging
Navigate
Back to articleFigure 3(3 of 8)
100%
Figure 3
Figure 3.Prevalence of ctDNA oncogenic mutations in the (A) PI3K pathway and loss-of-function mutations in (B) DNA damage response and (C) tumor suppressor pathways. ctDNA, circulating tumor-derived DNA.